|
|
U.S. judge approves suit against Bristol-Myers
NEW YORK (Reuters) - A U.S. judge ruled in favor of shareholders suing Bristol-Myers Squibb (BMY.N) about its disclosures while settling patent litigation with Canadian generic drug maker Apotex Inc over the blood-thinner Plavix.
Nations:U.S. Source:(Reuters)
2008-08-20
Merck Vioxx study was aimed at marketing: report
Reuters) - A 1999 clinical study that Merck & Co Inc (MRK.N) said was done to test side effects of painkiller Vioxx was conducted primarily to support a marketing campaign before the drug's launch, The Wall Street Journal said, citing a study.
Nations:India Activities:U.S. Painkiller Crisis Source:(Reuters)
2008-08-19
ImClone calls Bristol offer too low
PHILADELPHIA (Reuters) - Biotechnology company ImClone Systems Inc (IMCL.O) said on Monday that a $60-per-share takeover bid from partner Bristol-Myers Squibb Co (BMY.N) was too low, but it would hire financial advisers to help it study the unsolicited offer.
Nations:Japan Canada Germany People:Carl Icahn Martha Stewart Source:(Reuters)
2008-08-04
Bristol offers to buy Imclone for $60 a share
NEW YORK (Reuters) - Bristol-Myers Squibb Co (BMY.N) has offered to buy biotechnology company ImClone Systems Inc (IMCL.O) for $60 a share in a deal that would give it full control of the cancer drug Erbitux.
People:Carl Icahn Source:(Reuters)
2008-07-31
Prescription drug addictions rise
BOSTON (Reuters) - When Sarah Roisman was 11 years old, her doctors prescribed Klonopin, a muscle relaxant, for a psychiatric disorder that caused her to have seizures. She liked how the drug made her feel. Her seizures went away.
Nations:U.S. People:Joseph Biden Heath Ledger Anna Nicole Smith Source:(Reuters)
2008-07-30
| Headlines |
|
Matches Shown: | 1-50 | 51-100
|
|
|